{"id":89820,"date":"2026-01-18T13:07:17","date_gmt":"2026-01-18T13:07:17","guid":{"rendered":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/18\/mankind-pharma-launches-cutting-edge-digital-classrooms-bolstering-community-centric-education-through-kindcare-initiative-as-reported-by-india-education-diary\/"},"modified":"2026-01-18T13:07:17","modified_gmt":"2026-01-18T13:07:17","slug":"mankind-pharma-launches-cutting-edge-digital-classrooms-bolstering-community-centric-education-through-kindcare-initiative-as-reported-by-india-education-diary","status":"publish","type":"post","link":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/18\/mankind-pharma-launches-cutting-edge-digital-classrooms-bolstering-community-centric-education-through-kindcare-initiative-as-reported-by-india-education-diary\/","title":{"rendered":"Mankind Pharma launches cutting-edge digital classrooms, bolstering community-centric education through KindCare initiative, as reported by India Education Diary."},"content":{"rendered":"<p>Mankind Pharma, a leading pharmaceutical company, has launched digital smart classrooms as part of its KindCare initiative, aiming to revolutionize community-first education in India. The inauguration of these state-of-the-art classrooms marks a significant milestone in the company&#8217;s efforts to bridge the educational gap and provide quality learning opportunities to underprivileged students.<\/p>\n<p>The digital smart classrooms are equipped with modern technology, including interactive whiteboards, projectors, and high-speed internet connectivity. This infrastructure will enable students to access a wide range of educational resources, including e-learning materials, online tutorials, and virtual labs. The classrooms will also facilitate interactive learning experiences, allowing students to engage with teachers and peers in a more effective and immersive manner.<\/p>\n<p>The KindCare initiative is a testament to Mankind Pharma&#8217;s commitment to giving back to the community. The company has been actively involved in various corporate social responsibility (CSR) activities, focusing on education, healthcare, and environmental sustainability. By introducing digital smart classrooms, Mankind Pharma aims to empower students from disadvantaged backgrounds, providing them with the skills and knowledge necessary to succeed in an increasingly competitive world.<\/p>\n<p>The digital smart classrooms will cater to students from government schools and underprivileged communities, offering them access to quality education and resources that they may not have otherwise had. The initiative will also provide training and support to teachers, enabling them to effectively integrate technology into their teaching methods and create a more engaging learning environment.<\/p>\n<p>Mankind Pharma&#8217;s KindCare initiative has received praise from educators, policymakers, and community leaders, who recognize the potential of digital smart classrooms to transform the education landscape in India. The company&#8217;s efforts are aligned with the government&#8217;s Digital India initiative, which aims to promote digital literacy and connectivity across the country.<\/p>\n<p>By investing in digital smart classrooms, Mankind Pharma is not only contributing to the educational development of underprivileged students but also promoting social equity and inclusion. The company&#8217;s commitment to community-first education reflects its vision of creating a more just and equitable society, where every individual has access to quality education and opportunities for growth and development. As Mankind Pharma continues to expand its KindCare initiative, it is likely to have a profound impact on the lives of thousands of students, empowering them to achieve their full potential and create a brighter future for themselves and their communities.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Mankind Pharma, a leading pharmaceutical company, has launched digital smart classrooms as part of its KindCare initiative, aiming to revolutionize community-first education in India. The inauguration of these state-of-the-art classrooms marks a significant milestone in the company&#8217;s efforts to bridge the educational gap and provide quality learning opportunities to underprivileged students. The digital smart classrooms [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","fifu_image_url":"","fifu_image_alt":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[18,2],"tags":[],"class_list":["post-89820","post","type-post","status-publish","format-standard","hentry","category-mankind","category-pharma"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":89823,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/19\/mankind-pharma-launches-digital-smart-classrooms-initiative-in-ghaziabad-as-part-of-its-kindcare-corporate-social-responsibility-program\/","url_meta":{"origin":89820,"position":0},"title":"Mankind Pharma launches digital smart classrooms initiative in Ghaziabad as part of its KindCare corporate social responsibility program.","author":"Team Small News","date":"January 19, 2026","format":false,"excerpt":"Mankind Pharma, a leading Indian pharmaceutical company, has launched a digital smart classroom initiative in Ghaziabad as part of its corporate social responsibility (CSR) program, KindCare. The initiative aims to provide quality education to underprivileged students and bridge the digital divide in the region. The company has set up modern\u2026","rel":"","context":"In &quot;Mankind&quot;","block_context":{"text":"Mankind","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/mankind\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89744,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/03\/indias-pharmaceutical-sector-faces-a-pivotal-year-of-transformation-adapting-to-change-and-embracing-a-shifting-worldwide-landscape-hindustan-times\/","url_meta":{"origin":89820,"position":1},"title":"India&#8217;s pharmaceutical sector faces a pivotal year of transformation: Adapting to change and embracing a shifting worldwide landscape | Hindustan Times","author":"Team Small News","date":"January 3, 2026","format":false,"excerpt":"The Indian pharmaceutical industry has faced significant challenges in recent years, but 2022 has been a defining year for the sector. The industry has had to navigate disruptions caused by the COVID-19 pandemic, regulatory changes, and global trade tensions. Despite these challenges, Indian pharma has shown resilience and adaptability, and\u2026","rel":"","context":"In &quot;Pharma&quot;","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89792,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/13\/piramal-pharma-enhances-its-global-sustainability-rating-in-recent-corporate-assessment\/","url_meta":{"origin":89820,"position":2},"title":"Piramal Pharma Enhances Its Global Sustainability Rating in Recent Corporate Assessment.","author":"Team Small News","date":"January 13, 2026","format":false,"excerpt":"Piramal Pharma, a leading global pharmaceutical company, has achieved a significant improvement in its score on the Global Corporate Sustainability Assessment (CSA) conducted by S&P Global. The CSA is a widely recognized benchmark for assessing a company's sustainability performance, evaluating factors such as environmental, social, and governance (ESG) practices. In\u2026","rel":"","context":"In &quot;Pharma&quot;","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Piramal-Healthcare.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":89762,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/07\/the-high-court-has-asked-novo-nordisk-to-respond-to-natcos-request-to-cancel-its-patent\/","url_meta":{"origin":89820,"position":3},"title":"The High Court has asked Novo Nordisk to respond to Natco&#8217;s request to cancel its patent.","author":"Team Small News","date":"January 7, 2026","format":false,"excerpt":"The Delhi High Court has ordered Novo Nordisk, a Danish pharmaceutical company, to respond to a petition filed by Natco Pharma, a Hyderabad-based company, seeking to revoke the patent on the diabetes and anti-obesity drug semaglutide. The patent, which is set to expire in March, has been a subject of\u2026","rel":"","context":"In &quot;Natco&quot;","block_context":{"text":"Natco","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/natco\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89766,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/08\/anand-rathis-siddharth-sedani-reveals-his-top-4-stock-picks-do-they-feature-in-your-investment-portfolio\/","url_meta":{"origin":89820,"position":4},"title":"Anand Rathi&#8217;s Siddharth Sedani reveals his top 4 stock picks &#8211; do they feature in your investment portfolio?","author":"Team Small News","date":"January 8, 2026","format":false,"excerpt":"The Indian pharmaceutical sector is offering investors a chance to build a strong portfolio under the theme \"Ayush Kart\", as stated by Siddharth Sedani, Managing Director at Anand Rathi. The Indian pharma sector has been growing rapidly, and this trend is expected to continue, making it an attractive investment opportunity.\u2026","rel":"","context":"In &quot;Divi's Laboratories&quot;","block_context":{"text":"Divi's Laboratories","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/divis-laboratories\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/divis-lab-logo.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/divis-lab-logo.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/divis-lab-logo.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/divis-lab-logo.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":89842,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/23\/sun-pharma-receives-dcgi-approval-for-generic-version-of-wegovy-plans-march-release-ahead-of-semaglutide-patent-expiration\/","url_meta":{"origin":89820,"position":5},"title":"Sun Pharma receives DCGI approval for generic version of Wegovy, plans March release ahead of Semaglutide patent expiration.","author":"Team Small News","date":"January 23, 2026","format":false,"excerpt":"Sun Pharmaceutical Industries has received approval from the Drugs Controller General of India (DCGI) to launch a generic version of Novo Nordisk's Wegovy, a medication used to treat obesity. The approval comes as the patent for the active ingredient, semaglutide, is set to expire in March 2023. Wegovy, which contains\u2026","rel":"","context":"In &quot;Pharma&quot;","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"_links":{"self":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89820","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/comments?post=89820"}],"version-history":[{"count":0,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89820\/revisions"}],"wp:attachment":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/media?parent=89820"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/categories?post=89820"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/tags?post=89820"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}